• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details

Chemotherapy-induced Nausea and Vomiting: Recent Advances in Preventative Pharmacotherapy

Program Type



1 Contact Hour(s)

Release Date

Thursday, February 28, 2019

Offline Date:

Saturday, August 28, 2021

ACPE Expiration Date

Monday, February 28, 2022

Target Audience




  • Overview

    Chemotherapy induced nausea and vomiting (CINV) leads to morbidity and complications in care and occurs in up to 80% of patients[i]. Despite the recent advances in newly available antiemetics, approximately 50% of patients experience CINV which can have a severe effect on the cancer patient’s quality of life.  In addition to CINV having a substantial negative impact on the patient’s quality of life, it can also lead to chemotherapy delays, dose reductions, or discontinuation of therapy.  CINV can be a major barrier to therapy if not treated appropriately. With the development of therapy options in a wider range of classes, it is possible for more patients to better control their CINV. Antiemetic guidelines should be utilized when choosing CINV prevention therapy, both pharmacologic and non-pharmacologic. Nausea and vomiting prevention should be a combination of lifestyle and medication therapy to achieve the best possible results. 


    Homestudy PDF:   19137H01.pdf

    Financial Support By

    PharmCon, Inc.
  • Pharmacist

    Identify chemotherapy induced nausea and vomiting (CINV) risk factors of patients receiving chemotherapy
    List the antiemetic therapy agents available in the treatment of CINV
    Recommend an antiemetic regimen based on a patient's chemotherapy agent(s) and risk factors
    Identify 4 toxicities to consider with antiemetic therapy agents

  • Activity Type


    Universal Activity Number

    Pharmacist 0798-0000-19-037-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones

Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Firefox 3.0.3 or higher
Adobe Acrobat Reader

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).


©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.